Medicare Enrolled

Dr. Reena Patel, MD

Hematology & Oncology · Augusta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3696 WHEELER RD, Augusta, GA 30909
7067361830
Registered in NPPES since 2015
NPI: 1194108837 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Reena Patel is a hematology & oncology specialist in Augusta, GA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 78,844 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Patel received a total of $14,086 from 78 pharmaceutical and/or device companies across 581 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration ▲ Top 12% volume in GA $14,086 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
78,844
Medicare services
Top 12% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
39,750 $1 $2
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
17,850 $0 $2
Denosumab injection (Prolia/Xgeva) 5,340 $19 $48
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
4,795 $2 $6
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
4,650 $0 $1
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
956 $0 $1
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
721 $8 $13
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
678 $8 $68
Injection, granisetron hydrochloride, 100 mcg 550 $0 $1
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
548 $10 $67
Anti-nausea injection (Aloxi/palonosetron) 400 $1 $2
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
238 $91 $267
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
223 $21 $100
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
204 $13 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
190 $59 $158
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
177 $10 $75
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
167 $93 $722
Iron level test 160 $6 $40
Transferrin level test
A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body.
151 $12 $50
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
119 $45 $120
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
87 $15 $54
Red blood cell folate level test
A blood test that measures the amount of folic acid stored inside red blood cells to assess long-term folate status.
74 $17 $50
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
69 $6 $36
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
69 $1 $5
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
66 $101 $400
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
59 $128 $297
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
47 $46 $150
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
47 $1 $7
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
44 $3 $10
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 40 $20 $75
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
39 $21 $150
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
33 $8 $29
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
33 $3 $11
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
26 $15 $75
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
26 $61 $140
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
25 $9 $212
PSA test (prostate cancer screening) 23 $17 $60
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
22 $144 $600
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
21 $52 $350
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
21 $92 $209
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
21 $2 $2
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
20 $14 $30
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
19 $11 $75
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
17 $14 $50
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
17 $24 $220
New patient office visit, complex (60-74 min) 12 $144 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
73.9% high complexity
21.6% medium
4.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,086
Total received (2018-2024)
Avg $2,348/year across 6 years
Top 24% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
581
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,583
2023
$4,003
2022
$4,699
2021
$1,351
2020
$321
2018
$129

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$427
PFIZER INC.
$356
Merck Sharp & Dohme LLC
$302
AstraZeneca Pharmaceuticals LP
$274
E.R. Squibb & Sons, L.L.C.
$248
Daiichi Sankyo Inc.
$169
Stemline Therapeutics Inc.
$137
Celgene Corporation
$105
ABBVIE INC.
$101
TAIHO ONCOLOGY, INC.
$95
GlaxoSmithKline, LLC.
$85
Janssen Biotech, Inc.
$84
Genentech USA, Inc.
$77
Lilly USA, LLC
$70
Kite Pharma, Inc.
$60
BeiGene USA, Inc.
$53
ARRAY BIOPHARMA INC
$50
ADC Therapeutics America, Inc.
$50
Eisai Inc.
$49
GENZYME CORPORATION
$49
SOBI, INC
$46
Ipsen Biopharmaceuticals, Inc
$46
EMD Serono, Inc.
$43
Karyopharm Therapeutics Inc.
$42
Regeneron Healthcare Solutions, Inc.
$42
Alexion Pharmaceuticals, Inc.
$38
Deciphera Pharmaceuticals Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
Aveo Pharmaceuticals, Inc.
$33
JAZZ PHARMACEUTICALS INC.
$32
SpringWorks Therapeutics, Inc.
$28
Sumitomo Pharma America, Inc.
$23
Exelixis Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Gilead Sciences, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Blueprint Medicines Corporation
$20
Acrotech Biopharma Inc.
$20
MorphoSys, US Inc.
$19
Amneal Pharmaceuticals LLC
$19
SERVIER PHARMACEUTICALS LLC
$18
Pharmacosmos Therapeutics Inc.
$18
Octapharma USA, Inc.
$17
Organogenesis Inc.
$16
Genmab U.S., Inc.
$15
Mirati Therapeutics, Inc.
$14
Organon Llc
$14
Rigel Pharmaceuticals, Inc.
$11
Aspira Women's Health Inc
$7
Top 3 companies account for 30.3% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$2,030
Novartis Pharmaceuticals Corporation
$1,162
Regeneron Healthcare Solutions, Inc.
$829
AstraZeneca Pharmaceuticals LP
$654
E.R. Squibb & Sons, L.L.C.
$643
Seagen Inc.
$603
PFIZER INC.
$547
Merck Sharp & Dohme LLC
$545
Celgene Corporation
$489
Genentech USA, Inc.
$403
Janssen Biotech, Inc.
$374
GlaxoSmithKline, LLC.
$365
GENZYME CORPORATION
$271
Incyte Corporation
$243
TAIHO ONCOLOGY, INC.
$227
Amgen Inc.
$226
Lilly USA, LLC
$211
Stemline Therapeutics Inc.
$184
Exelixis Inc.
$180
G1 Therapeutics, Inc.
$174
SANOFI-AVENTIS U.S. LLC
$160
Takeda Pharmaceuticals U.S.A., Inc.
$141
Integra LifeSciences Corporation
$140
Merck Sharp & Dohme Corporation
$135
ABBVIE INC.
$131
Kite Pharma, Inc.
$130
ARRAY BIOPHARMA INC
$129
JAZZ PHARMACEUTICALS INC.
$118
AVEO Pharmaceuticals, Inc.
$115
Pharmacyclics LLC, An AbbVie Company
$111
Eisai Inc.
$107
Pharmacyclics LLC, an AbbVie Company
$106
Bayer Healthcare Pharmaceuticals Inc.
$103
BeiGene USA, Inc.
$100
Taiho Oncology, Inc.
$97
Gilead Sciences, Inc.
$96
Adaptive Biotechnologies Corporation
$95
Deciphera Pharmaceuticals Inc.
$90
Ipsen Biopharmaceuticals, Inc
$86
Acrotech Biopharma Inc.
$82
EMD Serono, Inc.
$75
Acrotech Biopharma LLC
$73
Alexion Pharmaceuticals, Inc.
$68
PUMA BIOTECHNOLOGY, INC.
$66
SERVIER PHARMACEUTICALS LLC
$66
Karyopharm Therapeutics Inc.
$65
Astellas Pharma US Inc
$64
Aveo Pharmaceuticals, Inc.
$63
Puma Biotechnology, Inc.
$62
Blueprint Medicines Corporation
$62
Bayer HealthCare Pharmaceuticals Inc.
$52
Rigel Pharmaceuticals, Inc.
$52
ADC Therapeutics America, Inc.
$50
SOBI, INC
$46
EUSA Pharma (US) LLC
$46
Sumitomo Pharma America, Inc.
$45
EISAI INC.
$41
TerSera Therapeutics LLC
$39
Genmab U.S., Inc.
$36
Foundation Medicine, Inc.
$36
AMAG Pharmaceuticals, Inc.
$33
MorphoSys, US Inc.
$33
SpringWorks Therapeutics, Inc.
$28
Mirati Therapeutics, Inc.
$28
Myovant Sciences Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
TG Therapeutics, Inc.
$21
Amneal Pharmaceuticals LLC
$19
Pharmacosmos Therapeutics Inc.
$18
Octapharma USA, Inc.
$17
Organogenesis Inc.
$16
AbbVie Inc.
$15
SECURA BIO, INC.
$15
Organon Llc
$14
Sobi, Inc
$13
PharmaEssentia USA Corporation
$13
Avanir Pharmaceuticals, Inc.
$12
Aspira Women's Health Inc
$7
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Avastin · BELEODAQ · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE CDX · Fabhalta · GILOTRIF · Gazyva · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NEXVIAZYME · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · ONZETRA Xsail · OPDIVO · OPDUALAG · ORGOVYX · OVA1 · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PURAPLY FRANCHISE · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TENOGLIDE TENDON PROTECTOR SHEET · TEPMETKO · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · Vanflyta · XALKORI · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Augusta?
Compare hematology & oncology specialists in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
28
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 12% in GA).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 39,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $14,086 from 78 companies across 581 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncology specialists in Augusta?
Dr. Patel's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →